Clinical Trial Update: Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA] [Phase 2]

View source ↗

Summary

This clinical trial update discusses a Phase 2 study (LUNA) evaluating the safety and efficacy of ADVM-022 in treatment-experienced patients with neovascular ag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• ADVM-022

Snippet

Sponsor: Adverum Biotechnologies, Inc. | Conditions: Neovascular Age-related Macular Degeneration | Phase 2 | Status: ACTIVE_NOT_RECRUITING